B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KYNU

MOLECULAR TARGET

kynureninase

UniProt: Q16719NCBI Gene: 89422 compounds

KYNU (kynureninase) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KYNU

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1l kynurenine1.795
2Kynurenine0.691

About KYNU as a Drug Target

KYNU (kynureninase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented KYNU interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KYNU inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.